Hosted by the Berkeley Public Library
2:00 pm - 4:00 pm
This free event is made possible by a generous gift from the Pace Trust, in support of the Berkeley Public Library North Branch.
For more information about this event, visit the library’s website: www.berkeleypubliclibrary.org. Wheelchair accessible. For questions, to request a sign language interpreter or other accommodations for this event, please call (510) 981-6195 (voice) or (510) 548-1240 (TTY); at least five working days will help ensure availability. Please refrain from wearing scented products to public programs.
Recently there has been a re-evaluation of popular psychedelic and empathogenic chemicals for therapeutic use. In the mid 1900s psychedelics such as LSD and MDMA were developed as pharmaceuticals. From the late 1960s on these drugs became associated with recreational use and by the 1980s most nations had outlawed them. Here in the Bay Area we have many scientists and clinicians on the forefront of the movement to bring these chemicals out of the clubs and counter-culture to explore their potential to treat a number of mental health conditions, including addiction and PTSD.
Join us for a free panel discussion on the current cultural, regulatory, and medical landscapes around these substances.
Prof. David Presti, PhD, UC Berkeley Department of Molecular and Cell Biology and author of Mind Beyond Brain: Buddhism, Science, and the Paranormal
Ayelet Waldman, author of A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life
Brad Burge, Director of Strategic Communications at the Multidisciplinary Association for Psychedelic Studies (MAPS)
Genesee Herzberg, PsyD, Psychologist at Sage Integrative Health
Moderated by Peter Leyden, Founder and CEO of Reinvent